K‐Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell lines

Advanced biliary tract cancer (BTC) has a poor prognosis and limited treatment options. The PI3K/Akt/mTOR signalling pathway is hyperactivated in a subset of BTCs, and clinical activity of the mTOR inhibitor everolimus has been observed in some patients with BTC. The goal of this study was to identi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeung, Yvonne, Lau, David K., Chionh, Fiona, Tran, Hoanh, Tse, Janson W. T., Weickhardt, Andrew J., Nikfarjam, Mehrdad, Scott, Andrew M., Tebbutt, Niall C., Mariadason, John M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579335/
https://www.ncbi.nlm.nih.gov/pubmed/28544747
http://dx.doi.org/10.1002/1878-0261.12078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579335/
https://www.ncbi.nlm.nih.gov/pubmed/28544747
http://dx.doi.org/10.1002/1878-0261.12078

Ejemplares similares